Graphic: corner
spacer
Graphic: corner
spacer spacer
nav left edge
nav right edge
spacer

Patents and Licenses

OptiGen holds the exclusive license for these tests from Cornell Research Foundation, Inc.:

    CEA/CH, US Patent No. 7462455; Canadian Patent No. 2,525,799; European Patent No. EP1652937

    CSNB US Patent No. 6,201,114 and US Patent No. 6,428,958

    prcd-PRA US Patent No. 5,804,388;  prcd-PRA Canadian Patent No. CA2306194; prcd-PRA UK Patent No. 2 341 926

    prcd-PRA Mutation US Patent No. 7,312,037; Australian, Canadian and European Patents AU2005202704, CA2507927, EP1609876

    prcd-PRA LD US Patent No. 7811761; Canadian and European Patents Pending No. 6256346.5

    RD/OSD US Patent No. 8,119,343; Australian Patent
    No. AU2008293550; Canadian Patent Pending CA2698202

Other Exclusive Licenses held by OptiGen:

OptiGen holds the exclusive license for CL testing in the U.S. and a non-exclusive license for other regions from the inventors at U. of New South Wales and the Border Collie Club of NSW, Australia, for this test. US Patent 7,723,034

OptiGen holds the exclusive license for this test from the inventors at the Swedish University in Uppsala, Sweden: CLAD Patent No. 6,210,897

OptiGen holds the exclusive U.S. and Canada license for this test from Merlogen, LLC: FN Patent No. 7,285,388

OptiGen is the exclusive authorized seller in the US of the Antagene test for NCL-A in the American Staffordshire and Pit Bull Terriers US Patent No 845,203

OptiGen is the exclusive authorized seller in the US of the Antagene Ichthyosis test for Golden Retrievers Patent Pending 13/510,620

OptiGen holds an exclusive license for use of patent No US 6140115 A for testing of GM1-Gangliosidosis in the Portuguese Water Dog

Other Licenses held by OptiGen:

OptiGen holds a license from the Animal Health Trust for GR_PRA2 testing in North and South America for Golden Retrievers. Patent Pending PCT/GB2013/051365

OptiGen holds a license from the Animal Health Trust for use of US patent No 8124337 for testing Hereditary Cataracts.

OptiGen tests are provided pursuant to a license from Genetic Technologies Limited for their Non-Coding/Mapping Patents.

OptiGen Sub-licenses:

Feb.1, 2015 OptiGen tests licensed to Specialist Diagnostic Services/Animal Network in Leichhardt NSW, Australia.


 


spacer
Graphic: footer bar left
OptiGen®, LLC · Cornell Business & Technology Park · 767 Warren Road, Suite 300 · Ithaca, New York 14850
Tel: 607 257 0301 · Fax: 607 257 0353 · email: genetest@optigen.com or optigen@clarityconnect.com
Graphic: footer bar right
spacer spacer
spacer
spacer
spacer